Introduction
Lung cancer is the leading cause of cancer mortality in the United States and the United Kingdom. Small cell lung cancer (SCLC) comprises 20% of all lung cancers (Kim et al., 2006) , is cigarette smoke induced in 90% of cases and has a very poor prognosis with early, widespread metastases (Jackman and Johnson, 2005) . In addition, SCLC is an aggressive neuroendocrine tumour capable of producing neuropeptides such as the adrenocorticotropin hormone (ACTH) precursor, proopiomelanocortin (POMC), gastrin-releasing peptide and neuromedin B. Up to 50% of patients with SCLC have biochemical or clinical features of aberrant ACTH production, although other features usually predominate at diagnosis (White et al., 1990; White and Clark, 1993) . The ectopic secretion of ACTH peptides in SCLC is characteristically insensitive to the normal negative feedback inhibition of circulating glucocorticoid (Gc); evidence of Gc resistance. In addition, chromosome 5, which includes the glucocorticoid receptor (GR) locus, is deleted in a number of SCLC (Mitelman, 2000; Tamura et al., 2002) . The evidence suggests that resistance to Gcs in SCLC is acquired by a reduction in the level of GR expression (Lu et al., 2005) . Murine knockout studies have shown that GR expression is essential for lung development and differentiation (Cole et al., 1995) , and, as SCLC results from the malignant transformation of a primitive progenitor cell, which then undergoes a pattern of dysdifferentiation (Minna et al., 2003; Kim et al., 2005) , it is possible that loss of GR expression in lung cancer cells may contribute to their malignant phenotype.
Gcs, acting through the GR, have diverse effects on different tissues and cell types. They inhibit the proliferation of many epithelial cell types, typically by causing prolongation of the G 1 phase of the cell cycle, by mechanisms which involve reduced expression of D-type cyclins or enhanced expression of cyclin-dependant kinase inhibitors p27 KIP or p21 WAF Sanchez et al., 1993; Rogatsky et al., 1997 Rogatsky et al., , 1999 Wang and Garabedian, 2003) . Gcs have also been shown to induce cell death in some cell types and promote survival in others (Schmidt et al., 2004) . In mammary epithelial cells, human and rat hepatocytes, vascular endothelial cells and osteoclasts, Gcs have been shown to inhibit apoptosis (Wu et al., 2004) whereas in T lymphoblasts, Gcs arrest proliferating lymphocytes in G 1 phase and then induce apoptosis by a process involving DNA binding of the activated GR (Norman and Thompson, 1977; Harmon et al., 1979; Norman et al., 1994; Kofler, 2000) . Gc treatment of some solid tumours is contentious, as it has been shown in some cell lines and xenograft models to prevent chemotherapy induced apoptosis (Herr et al., 2003; Pang and Conzen, 2004) ; however, the effect on SCLC treatment has not been investigated.
We have characterized previously a panel of human SCLC cell lines and found them to be deficient in GR expression and resistant to the actions of Gcs, both on a transfected reporter gene, and also on expression of the endogenous POMC gene Farrell et al., 1993; Ray et al., 1994 Ray et al., , 1996 . Loss of GR function may, therefore, confer a proliferative advantage to the SCLC cells by preventing activation of antiproliferative or proapoptotic pathways. To determine whether restoration of GR expression has an antiproliferative effect on SCLC cells, we induced expression of wild-type human GR by transfection and retroviral delivery techniques.
Results

GR expression is decreased in human SCLC cells
The three SCLC cell lines, DMS 79, DMS 53 and COR L24, contained dramatically less GR when compared to the human, non-small cell carcinoma cell line, A549, and the Gc-resistant HEK cell line (Figure 1a ). Gc exposure promotes rapid phosphorylation of Ser 211 in the GR. A549 cells showed the expected induction, but there was only a minor effect seen in HEK and DMS 79 cells. No detectable phospho 211 hGR was identified in either DMS 53 or in COR L24 cells (Figure 1a ).
Gcs do not inhibit growth of human SCLC cells
None of the three SCLC cell lines tested showed any growth inhibition in response to Gc exposure, in contrast to the non-SCLC cell line A549 (Figure 1b) . In addition, A549 cells transfected with Gc reporter genes showed Gc responses, but in contrast, neither the HEK cells nor the SCLC cell lines show any effect (data not shown, Ray et al., 1996; Garside et al., 2004) .
Transfection of SCLC cells with GR restores Gc mediated inhibition of proliferation and inhibits ACTH precursor secretion Transfection of GR-expressing plasmids into the SCLC cells confers Gc sensitivity on these normally resistant cells (Ray et al., 1994) . Such transfected cells were dispersed and cultured with or without dexamethasone, and colony formation in soft agar determined ( Figure 2a) . Furthermore, cells were cultured with or without dexamethasone, and cell proliferation determined by MTS assay (Promega, Madison, WI, USA) ( Figure 2b ). In both cases, restoration of GR expression in the SCLC cells resulted in inhibition of proliferation in response to dexamethasone exposure. However, it proved impossible to expand the clones sufficiently for definitive biochemical analysis due to the loss of cells with the restored Gc sensitivity phenotype. In contrast, HEK clones overexpressing GR (confirmed by qRT-PCR (quantitative real-time PCR), data not shown) were readily identified and cell number decreased after dexamethasone treatment (Figure 2c ). Both wild-type DMS 79 and wild-type COR L24 cells secrete ACTH precursors, which are unresponsive to Gc inhibition (Ray et al., 1996) . Expression of GR restored inhibition of ACTH precursor secretion in all the COR L24 colonies were analysed (Figure 2d ).
Retroviral delivery of GR-eYFP restores GR expression and function
As the introduction of wild-type GR into SCLC cells appeared to cause a major survival disadvantage to the cells, we sought alternative strategies that would result in larger numbers of transduced cells for analysis. To this end, we developed a panel of MMLV-based retroviral vectors containing the human GR expression cassettes, GR-eYFP fusion, GR-IRES-eYFP, with eYFP alone as control. Retroviral infection of DMS 79 cells showed expression of exogenous GR in GReYFP infected cells only (Figure 3) . Moreover, this exogenous GR became phosphorylated in response to dexamethasone treatment indicating that viral infection results in the production of functional GR (Figure 3 ). Further analysis of the viral vectors in HEK cells confirmed appropriate expression of the GR fusion protein, phosphorylation at Ser 211 in response to Gc treatment, translocation to the nucleus and activation of simple Gc reporter genes in response to Gc (data not shown). a) GR expression in human SCLC cells. Three SCLC cell lines, DMS 79, DMS 53, and COR L24, a non-SCLC cell line A549 and Gc-resistant HEK cells were cultured with or without 100 nm dexamethasone (dex) for 30 min before western blot analysis with antibodies to GR, phospho 211 hGR (P-GR) and tubulin, as indicated. (b) SCLC cell lines are insensitive to Gc action on proliferation. The cells described above were exposed to 100 nm dexamethasone or vehicle (DMSO) for 5 days, before proliferation was estimated by MTS assay. The standard deviations were less than 1% (*Po0.01, n ¼ 3). DMSO, dimethylsulphoxide; Gc, glucocorticoid; GR, glucocorticoid receptor; SCLC, small cell lung cancer.
GR expression profoundly impairs survival in two human SCLC cell lines DMS 79 and COR L24 cells were spinfected either with GR-eYFP, GR-IRES-eYFP or eYFP alone. After 72 h, the cells were analysed for eYFP fluorescence and propidium iodide (PI) exclusion. There was a marked reduction in viable, fluorescent cells after infection with the GR-eYFP-expressing virus in comparison to the eYFP-expressing virus, in both the cell lines in the absence of added ligand ( Figure 4a ). As this effect was the same with both the GR-eYFP fusion protein and GR-IRES-eYFP, but not eYFP alone, the loss of cell viability was solely due to GR protein expression (Figure 4a) .
Using a different batch of retroviruses, we counted the number of eYFP positive, dying (PI positive) cells in a mixed population of cells over a longer time course (21 days). Uninfected HEK and DMS 79 cells were stained with PI to determine the basal levels of dead or dying cells in the populations. More dead or dying cells were seen in uninfected DMS 79 cells due to preparation of spheroids for fluorescence-activated cell sorting (FACS) (Figure 4b and c). There was a massive increase in cell death in DMS 79 cells infected with GR-eYFP, compared to eYFP (57% compared to 26%). Neither virus affected the rate of cell death in HEK cells (o10%) (Figure 4b and c) . Cell imaging confirmed these observations with very few GR-eYFP-positive cells seen following infection of DMS 79 cells.
GR antagonist opposes cell death in GR-infected SCLC cells
The loss of fluorescent cells after GR-eYFP viral infection was observed in the absence of added ligand, although cells were cultured in serum (which contained Gcs), to promote cell growth and so retroviral infection. Surprisingly, dexamethasone did not cause any additional loss of GR-eYFP-positive cells, but incubation with RU486 appeared to protect the cells from death ( Figure 4d ). Neither dexamethasone nor RU486 Figure 3 Retroviral infection of DMS 79 cells results in overexpression of a functional GR. DMS 79 cells were spinfected with retroviral GR-eYFP or control eYFP as described. Seventy-two hours after infection, cells were exposed to 100 nm dexamethasone for 30 min before western blot analysis with antibodies to phospho 211 hGR (P-GR), GR and tubulin. Exogenous GR and phospho 211hGR are indicated by black arrowheads, whereas the endogenous proteins are marked by open arrowheads. GR, glucocorticoid receptor. Figure 2 Overexpression of GR restores Gc signalling in SCLC cells causing a decrease in proliferation rate upon Gc exposure. (a) GR-transfected DMS 79 and COR L24 cell clumps were dispersed (o5 cells) and seeded with or without 100 nm dexamethasone in six-well plates in soft agar. Formation of new colonies (>50 cells) was determined by counting under the microscope using a Â 10 objective at 28 days (*Po0.05). (b) COR L24 cells were transfected with GR, selected in G418 and the surviving cell clumps dispersed and cultured with or without 100 nm dexamethasone for 48 h before the MTS assay (Promega) (*Po0.05). (c) Adherent HEK cells were transfected, selected in G418 and counted after 5 days exposure to 100 nm dexamethasone (*Po0.05). (d) Restored Gc signalling allows inhibition of secretion of ACTH precursors. Four COR L24-GR clones were analysed for ACTH precursor peptide secretion. Cells were incubated with 100 nm dexamethasone as indicated for 48 h before ACTH precursors were measured. The standard deviations were less than 10% (*Po0.01, n ¼ 3). ACTH, adrenocorticotropin hormone; Gc, glucocorticoid; GR, glucocorticoid receptor; SCLC, small cell lung cancer. Overexpression of GR is sufficient to activate target genes in the absence of ligand As overexpression of GR in the DMS 79 and COR L24 cells caused loss of cell viability even in the absence of added Gc, this suggested that there was either a ligandindependent effect or that Gc present in the serum was sufficient to activate the overexpressed GR. Therefore, the functional consequence of overexpressed GR was analysed in the presence of serum or dextran-charcoalstripped serum (to remove steroids). Exogenous GR transactivated the TAT3-luciferase reporter gene construct in both HEK and DMS 79 cells in response to dexamethasone, as expected (Figure 5a and b). Exogenous GR also transactivated the reporter construct in the absence of added Gc, both in medium containing normal serum and stripped serum (Figure 5a and b). Similar results were seen using retroviral expression of GR.
GR overexpression causes cell death in sorted populations
As viral infection only achieved a low infection rate particularly in the GR-eYFP-infected cells, our next aim was to sort pure populations of eYFP and GR-eYFP- Cells were incubated in the appropriate medium containing either 10% FBS (whole serum) or 10% charcoal stripped FBS (stripped serum) and exposed to 100 nm dexamethasone or vehicle for 16 h prior to harvesting for the Dual Luciferase Assay (*Po0.05, n ¼ 3). The absolute luciferase values were lower in DMS79 cells due to low transfection efficiency of the cells, and also the possible adverse effects of GR expression. FBS, foetal bovine serum; GR, glucocorticoid receptor. 
Retroviral expression of GR induces apoptosis in SCLC cells
To determine the mode of cell death, flow cytometric samples were stained with Annexin V, a marker of early apoptosis. The apoptotic index of HEK cells infected with eYFP and GR-eYFP was low with approximately 2% of the eYFP-positive populations staining with Annexin V (data not shown). Unsurprisingly, the apoptotic index of DMS 79 cells infected with control and test viruses were significantly higher, due to the stresses involved in preparation for flow cytometry (Figure 7a and b) . However, majority of cells expressing GR-eYFP were Annexin V-positive, in contrast to cells expressing eYFP alone (Figure 7a and b) . It is also interesting to note that in the cells infected with the GR-eYFP virus, there was also an increase in the proportion of apoptotic cells in the apparently non-GReYFP-expressing subpopulation (Figure 7a ). It may be that some cells committed to apoptosis lose GR-eYFP expression, as the apoptotic programme is elaborated. Further evidence of the proapoptotic effect of GR expression was obtained by microscopy of fixed cells. DMS 79 cells expressing GR-eYFP displayed fragmenting nuclei, typical of apoptosis (Figure 7c) . Enumeration of fragmenting nuclei in eYFP and GR-eYFP-infected cells revealed that significantly more cells expressing GR-eYFP had fragmenting nuclei typical of apoptosis compared to cells expressing just eYFP (Figure 7d ). GReYFP was seen mainly in the cell nucleus, which may explain why it was transcriptionally active. 
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Overexpression of GR in the SCLC cell line, DMS 79, causes an upregulation of proapoptotic genes Microarray analysis was performed to determine the genetic pathways affected by GR overexpression. The transcriptome of DMS 79 cells infected with GR-eYFP was compared to that of cells infected with the virus expressing eYFP at 72 h after infection, the time at which the transgene was clearly expressed, and at which cell death was already manifest. Analysis of the array data revealed that augmented GR expression, under the same conditions that resulted in apoptosis of target cells, regulates numerous genes. The data were analysed using GeneGo software (www.genego.com) to determine if the GR-regulated genes grouped into any major networks. The most over-represented networks were shown to be those involved in apoptosis. Confirmation of the array data by quantitative PCR revealed that GR overexpression in SCLC cells resulted in a twofold upregulation of the proapoptotic genes, BCL2-antagonist of cell death (BAD) and BCL2-associated X protein (BAX) (Figure 8a ) as well as upregulation of metallothionein 1X (MT1X), a well-characterized GR responsive marker gene (Hernandez et al., 2000) . Furthermore, upregulation of BAD was confirmed at the protein level by immunocytochemistry (Figure 8c and d ). It appears that while GR-eYFP expression is more nuclear, BAD expression appears more cytoplasmic as expected. In addition, several genes were confirmed by qPCR to be downregulated by GR including ADAM (metallopeptidase domain 19 meltrin-b) in agreement with our results in primary human T lymphocytes (Donn et al., 2007) , cyclin D2 (CCND2), dedicator of cytokinesis 1 (DOCK1), phosphatidylinositol-4-phosphate 5-kinase, type II, alpha (PIP5K2A) (Figure 8b ). 
Discussion
We have discovered an unexpected and highly significant GR-mediated effect on human SCLC cell viability. By extending earlier observations, we have shown that human SCLC cells are profoundly resistant to Gc action, due to deficient GR expression. A correlation between decreased GR expression and resistance to the antiproliferative effects of Gc in human small cell carcinoma has been noted before, but the mechanism has not been explored (Hofmann et al., 1995) . In solid tumour models, a correlation between GR content and Gc sensitivity has also been described (Braunschweiger et al., 1983) . The abundance of GR is, therefore, an important factor in Gc resistance and it has been shown in a number of cell models, including ours, that there appears to be a threshold effect, with a critical concentration of receptors required for GR activity.
In the current study, expression of GR by transfection or retroviral infection restored Gc sensitivity and had a profound negative effect on cancer cell viability suggesting that acquisition of Gc resistance in a subset of SCLCs confers a survival advantage to the cells. Cell death mediated by retroviral overexpression of GReYFP in mixed cell populations occurred in the absence of added ligand, but the cells were cultured in 10% feotal bovine serum (FBS). Overexpression of GR-IRES-eYFP caused the same loss of cell viability, indicating that the death of live fluorescent cells can be confidently ascribed to ectopic overexpression of the GR.
The dramatic decrease in live fluorescent cells on infection with the GR transgene was seen under basal growth conditions, dexamethasone resulted in a further small decrease in live fluorescent cells, and RU486 reversed the effect. These data support the importance of authentic GR activity in mediating the antiproliferative effect.
The dramatic effects on cell viability seen in cells overexpressing GR suggested either a ligand independent effect, or possibly a low ligand concentration threshold that was exceeded by Gc present in the serum. We show that, in cells cultured with either 10% serum or 10% charcoal-stripped serum, there was an induction in reporter gene activity seen even in the absence of added dexamethasone. In fact, previous reports support the existence of ligand-independent effects of GR expression. In one study, overexpressed GR inhibited the activity of Nuclear factor-kB, and in further work, a similar conclusion was reached, even when a mutated GR was expressed with disrupted nuclear localization function (Mathieu et al., 1999; Doucas et al., 2000) .
To investigate further whether the loss of live fluorescent cells was due to failure of integration and expression of the transgene or to loss of cells overexpressing transgene, fluorophore-expressing cells were FACS sorted into pure populations, and analysed over time. The number of live fluorescent cells decreased over 72 h to zero in the GR-eYFP sorted cells while the eYFP-positive population in control, eYFP-infected cells continued to proliferate unimpeded after an initial decline in numbers. Cell death appeared to be accelerated in these sorted populations, possibly because the more highly expressing cells were selected. This experiment was performed on cells cultured in 10% charcoal-stripped serum supplemented with either 100 nM dexamethasone or vehicle. Cell death was not affected by dexamethasone exposure. This observation, taken with the earlier data showing that GR overexpression alone is sufficient to activate at least some target processes suggests a much higher sensitivity to low Gc concentrations or a truly ligand-independent effect. Either way, this suggests that SCLC cells are exquisitely sensitive to GR overexpression, which is quite unlike the equally Gc insensitive HEK cell line.
We sought to investigate the mechanism for the striking survival disadvantage conferred on the SCLC cells by GR overexpression. The GR has been shown to impair proliferation in murine macrophages, keratinocytes and osteosarcoma cells Sanchez et al., 1993; Rogatsky et al., 1997) , but induce apoptosis in T lymphoblasts (Leis et al., 2004; Zhu et al., 2004) . When examining SCLC cells following infection with the GR-eYFP construct, we found a striking increase in apoptotic cells, measured both by Annexin V binding and also nuclear morphology. It is well established that Gcs cause growth arrest in many different cell types, but apoptosis is relatively specific to T lymphoblasts and this makes our study in SCLC cells novel.
A transcriptome mapping study was performed to identify genes regulated by expression of GR in the SCLC cells. Analysis of the array data revealed that all the predominant networks affected by GR overexpression appeared to be involved in apoptosis. This was confirmed for a selected subset of regulatory events by qRT-PCR and, for the proapoptotic factor BAD, at the protein level.
While extensive microarray studies have been performed to identify the Gc-regulated genes responsible for the induction of apoptosis, the results are conflicting and very few are consistently found (Schmidt et al., 2004) suggesting that distinct sets of genes might be regulated in different cell systems and experimental conditions. However, a previous array study to find GRregulated genes in phytohaemaglutinin-stimulated peripheral blood mononuclear cells showed upregulation of STAT1 and BAD in agreement with our results (Galon et al., 2002) . Although no direct regulation of BAD by GR has been shown previously, Gc-induced apoptosis in primary T cells in vivo and in vitro is associated with a significant upregulation of BAD (Mok et al., 1999) .
The microarray data, taken with the morphological, proliferative and Annexin V, studies suggest a coordinated cell response to GR expression, leading to activation of an apoptotic programme. It is known that Gc-induced apoptosis is dependant on sufficient levels of functional GR and subsequent alterations in gene expression. However, the mechanisms by which Gcs induce apoptosis differ between cell types (Reichardt et al., 1998; Schmidt et al., 2004) . In lymphocytes, Gc treatment causes a downregulation of the anti-apoptotic genes, BCL-2 and BCL-xL (Herr et al., 2003) . SCLC tumours typically display an upregulation of these antiapoptotic genes, the expression of which has been associated with chemoresistance (Mortenson et al., 2005) .
Currently Gcs are widely used in the treatment of inflammatory disorders, but they are also used both in the therapeutic induction of apoptosis in malignant lymphoid cells and as adjunctive agents in conventional chemotherapy of solid tumours (Herr et al., 2003) . Therefore many patients with solid tumours, including lung cancers, currently receive Gc therapy. Ours is the first evidence that Gc-activated pathways have a proapoptotic action in human SCLC, but only when GR expression exceeds a critical threshold. Moreover, our data suggest that the evasion of Gc signalling in human SCLCs will provide a significant survival advantage for the transformed cells, compatible with earlier observations showing a chemoprotective role of Gcs in lung cancer development (Witschi et al., 2005) .
In summary, overexpression of GR in human SCLC cells by retroviral vector, leads to a dramatic loss of SCLC cell viability. We have shown that this loss of cell viability is dependent on the expression of the transgene and is associated with a dramatic increase in the rates of apoptosis seen in cells, which express the GR-eYFP transgene. Understanding how the cancer cells become resistant to Gcs and more importantly how Gc signalling causes loss of cell viability may lead to novel therapeutic approaches.
Materials and methods
Cell culture DMS 79 and CORL 24 cells (gifts from Dr O Pettengill, Dartmouth Medical School, Hanover, NH, USA and Dr P Twentyman, UKCCCR, Lincoln Inn Fields, London, UK, respectively), and HEK 293 cells (ECCAC, Porton Down, Wilts, UK) were cultured as described (Ray et al., 1994) .
Western blots
Proteins were extracted from cells exposed to 100 nM dexamethasone or vehicle for 30 min by lysing cells with RIPA buffer containing protease and phosphatase inhibitors. Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and probed with tubulin (Sigma, Gillingham, UK), Clone DM1A), GR (BD Transduction Laboratories, Cowley, UK) clone 41) and phospho 211 hGR (Cell Signalling Technology, Beverly, MA, USA).
Proliferation and MTS assays HEK, A549, CORL51 and DMS 79 cells were seeded at a density of 1 Â 10 5 cells/ml. CORL 24 and DMS 53 cells were seeded at a density of 5 Â 10 5 cells/ml. Cells were either exposed to 100 nM dexamethasone or vehicle for 5 days, before cell counting by haemocytometer, or MTS assay (Promega). Each experiment was performed in triplicate.
Stable transfections DMS 79 and CORL 24 cells (5 Â 10 5 ) were transfected using 10 ml DMRIEC (Gibco, Paisley, UK) per 1 mg pcDNA3-GR. Successfully transfected cells were selected by exposure to G418 (400 mg/ml) for 2-4 weeks and individual colonies isolated. Individual colonies were dispersed (o5 cells/clump), resuspended in 6 ml medium supplemented with 400 mg/ml G418 and seeded, with or without 100 nM dexamethasone (Sigma), into soft agar medium for 28 days. The effect of restoration of Gc signalling and subsequent dexamethasone stimulation on the metabolic activity of three CORL24 cell lines was assessed after incubating the cells with or without dexamethasone for 48 h in a 96-well plate using the MTS assay (Promega). HEK cells were transfected using FuGene 6 (Roche, Lewes, UK). Viable, adherent G418-selected HEK cells were counted by Trypan blue exclusion in the presence or absence of 100 nM dexamethasone for 5 days.
Retroviral infections
HEK packaging cells were transfected with pFUNC1-eYFP or pFUNC1GR-eYFP, pVack-gag-pol (BD Biosciences, Clontech) and pVpack-VSVG (BD Biosciences, Cowley, UK) plasmids using calcium phosphate precipitation as per the manufacturer's protocol (Promega). At 24 h post-transfection, the cells were treated with 100 mM sodium butyrate (Sigma). At 48 h post-transfection, supernatant containing the retroviral particles was removed and used to infect DMS 79, COR L24 and HEK cells. DMS 79 and COR L24 cells were transduced with retroviral supernatant by two lots of spinfection (2500 r.p.m. for 2 h) on consecutive days. HEK cells were infected by layering retroviral supernatant onto the cell monolayer for 6 h, then repeating the following day. All infections were carried out in the presence of 8 ug/ml polybrene (Sigma). Post-infection, cells were cultured in normal growth media containing serum.
ACTH precursor assay ACTH precursors were measured using a specific two-site enzyme-linked immunosorbent assay based on an IRMA format described previously (Crosby et al., 1988) .
Reporter assays HEK cells were transfected as described (Ray et al., 1994; Garside et al., 2004) with 10 mg TAT3-luciferase reporter construct and 5 mg pcDNA3-GR or control pcDNA3 using FuGene 6 (Roche). In addition, the cells were transfected with 2 mg pRLCMV to control for transfection efficiency. Cells were exposed to 100 nM dexamethasone for 16 h before harvesting for the Dual Luciferase Assay (Promega).
Quantitative PCR DMS 79 and HEK cells were spinfected or infected with GReYFP or eYFP viruses. RNA was extracted from the cells 72 h post-infection (RNeasy kit, Qiagen, Crawley, UK). After DNAse 1 treatment (Promega), cDNA was synthesized using Superscript 111 (Invitrogen) and Oligo-dT primers (Invitrogen). Quantitative PCR was performed using SYBR Green JumpStart Taq ready mix (Sigma) as per the manufacturer's instructions. Primer sequences on request, analysis was by 2
ÀDDCt method (Livak and Schmittgen, 2001 ).
Flow cytometry HEK and DMS 79 cells at a density of 3-4 Â 10 6 /ml were drawn up through a 0.4 Â 12 mm needle and expelled through a 40mm cell strainer into phosphate-buffered saline (BD Falcon, Le Pont declaix, France) to create a single cell suspension. Cells were analysed for eYFP (530/40 nm) (infected cells) on a DakoCytomation Cyan flow cytometer using Summit software (DakoCytomation, Ely, UK). For the viability experiments, cells were then stained with PI and analysed for red fluorescence (613/20 nm). Cells were then gated to determine the percentage of eYFP and PI-positive cells. For the apoptosis assays, the pelleted cells were resuspended in buffer (10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES); 10 mM NaOH; 140 mM NaCl; 25 mM CaCl 2 ), strained, incubated with 5 ml human recombinant APC-conjugated Annexin V (Bender MedSystems, Vienna, Austria) at room temperature for 15 min and analysed at 665/20 nm. Cells (10 000) were then gated to determine the percentage of eYFP and Annexin V-positive cells.
For cell-sorting assays, eYFP-positive DMS 79 cells at 72 h post-infection were sorted into serum-free RPMI containing 1% HEPES and penicillin streptomycin (Gibco) using a FACSAria (BD Biosciences). Cells were cultured in RPMI containing 1% HEPES and 10% stripped FBS (Invitrogen) and exposed to either 100 nM dexamethasone or vehicle.
Pharmacological blockade DMS 79 cells were infected with either GR-eYFP or eYFP alone. Infected cells were then exposed to either 100 nM dexamethasone, 100 nM RU 486 or medium containing diluent dimethylsulphoxide as a control. Cells were analysed by FACS as described after 72 h.
Apoptosis analysis and immunofluoresence
Seventy-two hours after infection, DMS79 cells were pelleted and fixed with 4% paraformaldehyde. Cryo-sections were mounted with hard set mounting medium containing 4,6-diamidino-2-phenylindole DAPI (Vector Laboratories, Peterborough, UK) and analysed for eYFP fluorescence. For immunostaining, sections were stained with BAD antibody (Cell Signalling Technology) and detected with Texas Red-labelled secondary antibody (Invitrogen). Images were taken using a Leica TCS-4D confocal microscope (Leica Microsystems) using a Â 63 water immersion objective. For quantitation, the fluorescence intensity of Texas red in transfected and untransfected cells was quantitated using Image J software.
Statistical analysis
Simple comparisons between two groups were made using Student's t-test for parametric, and Mann-Whitney U-test for non-parametric data. Comparisons involving more than two groups were by analysis of variance followed by Bonferroni t-test.
Microarrays RNA was extracted 72 h after infection from DMS 79 cells using the Qiagen RNAeasy kit (Qiagen). RNA was reverse transcribed, labelled and hybridized to Human Genome U133 Plus 2 oligonucleotide arrays (Affymetrix, High Wycombe, UK) according to the manufacturer's instructions at the University of Manchester Microarray Facility. Arrays were read using Agilent GeneArray scanner 3000 m 7G Affymetrix GCOS (V1.4) software. Technical quality control of the arrays was done to check for outliers using dChip software (Li and Wong, 2001) . Normalization and expression analysis was done using RMA (Bolstad et al., 2003) . Differential expression was assessed with a modified t-test on the logarithmically scaled data using Cyber-T (Baldi and Long, 2001) . A gene list of differentially expressed genes was generated using criteria of Cyber-T Po0.05 and mean-fold change greater than 1.5.
